• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXSS2400105 培集成干扰素α-2注射液 Peginterferon alfacon-2 Injection Biological Products(2.2) New Drug Application 2024-09-30 Beijing Kawin Technology Share-Holding Co Ltd view
CXSL2300345 培集成干扰素α-2注射液 Peginterferon alfacon-2 Injection Biological Products(2.2) New Drug Application 2023-05-17 Beijing Kawin Technology Share-Holding Co Ltd view
CXSB2300020 培集成干扰素α-2注射液 Peginterferon alfacon-2 Injection Biological Products Supplementary Application 2023-02-25 Beijing Kawin Technology Share-Holding Co Ltd view
CXSL2200464 培集成干扰素α-2注射液 Peginterferon alfacon-2 Injection Biological Products(2.2) New Drug Application 2022-09-16 Beijing Kawin Technology Share-Holding Co Ltd view
CYSB2200225 培集成干扰素α-2注射液 Peginterferon alfacon-2 Injection Biological Products Supplementary Application 2022-09-09 Beijing Kawin Technology Share-Holding Co Ltd view
CXSS1500020 聚乙二醇化重组集成干扰素变异体注射液 Peginterferon alfacon-2 Injection Biological Products(9) New Drug Application 2017-01-03 北京凯因科技股份有限公司 Beijing Kawin Technology Share-Holding Co Ltd Certificate Issued 2018-07-06 view
CXSB1000014 聚乙二醇化重组集成干扰素变异体注射液 Peginterferon alfacon-2 Injection Biological Products Supplementary Application 2010-05-27 重庆富进生物医药有限公司 Chongqing Fujin Biological Medicine Co Ltd Certificate Issued 2011-04-12 view
CXSL0600026 聚乙二醇化重组集成干扰素变异体注射液 Peginterferon alfacon-2 Injection Biological Products(9) New Drug Application 2006-06-05 重庆富进生物医药有限公司 Chongqing Fujin Biological Medicine Co Ltd Certificate Issued 2009-12-25 view